Skip to main content
Canadian medtech company obtains $7.6M in funding round

A round of Series A venture capital financing has brought in approximately $7.6 million for Evasc Neurovascular Enterprises, a Canadian medical device company that develops endovascular treatments for cerebral aneurysms. The proceeds will be used to support product development and commercialization.

Full Story: